Clinical studies have shown that psoriasis patients treated with GLP-1 agonists (such as liraglutide or semaglutide ) experienced a significant improvement in their symptoms
Diabetes Care 26(3):881885 Nakatani Y, Maeda M, Matsumura M, Shimizu R, Banba N, Aso Y et al (2017) Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy
No hospitals, no waiting rooms
Use of GLP-1 analogue drugs is associated with benefits but also health risks The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and obesity, may be associated with a wide range of health effects, both positive - such as a reduced risk of cardiometabolic disorders - and negative - an increased risk of gastrointestinal conditions or hypertension
Social media listening is a powerful tool for extracting insights quickly and efficiently from text content (28)
Under oxidative stress, lipid peroxidation is observed in LDL and arterial wall cells, leading to the formation of atheromatous plaques
